Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Market Value Is The Female Fertility And Pregnancy Rapid Test Industry Expected To Reach By 2029, Starting From 2025 Levels?
The overall valuation of the market segment dedicated to rapid testing for female fertility and pregnancy has demonstrated robust expansion lately, projected to advance from $1.4 billion in 2024 to reach $1.48 billion by 2025, reflecting a consistent compound annual growth rate of 5.2 percent; this upward trajectory during the historical timeframe is linked to factors such as heightened knowledge regarding reproductive wellness, an increasing tendency to postpone parenthood, shifts in cultural and societal norms, the advancing average age for mothers, and the ease of accessibility for these testing kits without a prescription.
Anticipation surrounds the female fertility and pregnancy at-home testing sector, projecting substantial expansion over the coming years, with valuation set to reach $1.93 billion by 2029, driven by a compound annual growth rate (CAGR) of 7.0%; this upward trajectory is being fueled by several factors including the increasing focus on personalized medical treatments, a growing preference for methods of natural family planning, the proliferation of fertility tourism worldwide, supportive governmental programs encouraging family planning efforts, and the introduction of more accessible and cost-effective healthcare solutions, while key shifts shaping the market involve the incorporation of digital health technologies, wider acceptance of telehealth services, growing collaboration among healthcare entities, the increasing sales via e-commerce for test kits, and ongoing advancements in tests designed to predict ovulation.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8966&type=smp
Which Industry Drivers Are Expected To Accelerate The Female Fertility And Pregnancy Rapid Test Market From 2025 To 2029?
Anticipated expansion in the prevalence of female reproductive system ailments is projected to primarily fuel the advancement of the market encompassing rapid tests for female fertility and pregnancy. A gynecological ailment constitutes any pathological condition impacting the female reproductive structures, encompassing mammary glands and the abdominal and pelvic viscera such as the uterus, ovaries, vaginal canal, oviducts, and vulva. Assessments for fertility may be conducted to pinpoint ovulation or to establish a diagnosis of infertility, characterized as the failure to achieve natural conception, thereby contributing to the mitigation of gynecological issues. To illustrate this, data shared in July 2022 via a publication from the US National Library of Medicine indicated that the frequency of specific gynecological disorders comprises uterine fibroids at 14.23 percent, spontaneous abortion at 13.20 percent, ovarian dysfunction at 11.16 percent, endometriosis at 4.09 percent, polycystic ovary syndrome at 19.04 percent, and painful menstruation (dysmenorrhea) at 45.96 percent. Consequently, the rising rates of these gynecological conditions serve as a significant impetus for the expansion observed in the market for rapid fertility and pregnancy testing targeted at women.
What Are The Major Segment Categories Driving The Female Fertility And Pregnancy Rapid Test Market Growth?
The female fertility and pregnancy rapid testmarket covered in this report is segmented –
1) By Product: Fertility Rapid Test Kits, Pregnancy Rapid Test Kits
2) By Device Type: Digital Devices, Line-indicator Devices
3) By Test Type: FSH Urine Test, LH Urine Test, hCG Blood Test, hCG Urine Test
4) By Distribution Channel: Hospital Channel, Retail Channel, Online Channel
Subsegments:
1) By Fertility Rapid Test Kits: Ovulation Predictor Kits, Luteinizing Hormone (LH) Test Kits, Follicle-Stimulating Hormone (FSH) Test Kits
2) By Pregnancy Rapid Test Kits: Urine-Based Pregnancy Tests, Blood-Based Pregnancy Tests, Combo Fertility And Pregnancy Tests
What Are The Latest Industry Trends Transforming The Female Fertility And Pregnancy Rapid Test Market?
A prominent trend currently shaping the landscape of the female fertility and pregnancy rapid test sector involves the introduction of new product solutions. Leading industry players are actively engaged in creating novel testing devices as a means to secure and maintain their standing within the market. For example, back in November 2022, Salignostics, an Israeli firm focused on the research and creation of diagnostic tests utilizing saliva, brought forth Sailstick, a pregnancy assessment tool that employs saliva. This device marks a significant milestone as the inaugural rapid pregnancy test operating via saliva, offering both superior user experience and precision in identifying gestational beginnings. Its functionality is rooted in the firm’s revolutionary platform engineered to detect the pregnancy-related hormone HCG within saliva samples. Users of this kit simply place one element of the testing apparatus into their mouth for a brief duration to gather their saliva sample, subsequently inserting it into a testing vial, with outcomes being displayed in under ten minutes.
Which Leading Players Are Enhancing Their Female Fertility And Pregnancy Rapid Test Market Presence Worldwide?
Major companies operating in the female fertility and pregnancy rapid test market include Abbott Laboratories, Atlas Medical GmbH, bioMérieux SA, Church & Dwight Co. Inc., Quidel Corporation, Egens Group, Eurofins Scientific SE, Everlywell Inc., Genea Pty Limited, Geratherm Medical AG, SA Scientific Ltd., Artron Laboratories Inc., PRIMA Lab SA, The Procter & Gamble Company, Alere Inc., Prestige Brands Holdings Inc., SPD Swiss Precision Diagnostics GmbH, Fairhaven Health LLC, Fertility Focus Limited, HiLin Life Products Inc., Inverness Medical Innovations Inc., UEBE Medical GmbH, Wondfo Biotech Co. Ltd.
Download The Full Report For Exclusive Market Findings:
Which Global Regions Are Influencing The Competitive Landscape Of The Female Fertility And Pregnancy Rapid Test Market?
North America was the largest region in the female fertility and pregnancy rapid test market in 2024. The regions covered in the female fertility and pregnancy rapid test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Female Fertility And Pregnancy Rapid Test Market Report:
https://www.thebusinessresearchcompany.com/customise?id=8966&type=smp
Browse Through More Reports Similar to the Global Female Fertility And Pregnancy Rapid Test Market 2025, By The Business Research Company
Epoxy Resin Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/epoxy-resin-global-market-report
Chromatography Resins Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/chromatography-resins-global-market-report
Specialty Resins Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/specialty-resins-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model